Wednesday, October 31, 2012

News Items and Resources from the Publishers of 2e: Twice-Exceptional Newsletter

AD/HD MEDS AND "SELF." Maybe  you've heard it from your gifted and AD/HD child -- that he or she is concerned that AD/HD meds will somehow cause a personality change. David Rabiner, at, writes about a study looking into that issue. According to Rabiner, the study found that "nearly 40% of stu­dents who dis­con­tin­ued med­ica­tion reported con­cerns that using med­ica­tion com­pro­mised their true self in some essen­tial way." Read more. Separately, we've noticed that Rabiner has not posted recent  issues of Attention Research Update at his website. If  you're interested in seeing those issues in a timely way, consider signing up at 

SMARTPENS AT PENN STATE. The university's Office of Disability Services is issuing LiveScribe smartpens to students who may benefit from them. The pens record lecture-hall audio and digitize notes the student takes so that the student may easily access content from the lecture at a later time. Find out more

MISSED THIS AT THE TIME. In August, Dr. Steven Hyman did a Q&A with the Boston Globe on the topic of drugs to treat conditions like depression, anxiety, schizophrenia, bipolar disorder, AD/HD, OCD, and  autism. Interviewer and interviewee noted a bad trend: that big drug companies don't seem interested in developing new drugs for those conditions. Said the doctor, "The pharmaceutical industry is basically giving up and throwing in the towel. Their exit is both a symptom of the difficulty and a problem." Read more

SENGINAR. SENG is presenting a webinar on November 8th titled "Developing Internal Motivation in Gifted Youth." It will be presented by Lisa van Gemert, who is the gifted youth specialist for Mensa. Find out more

WRIGHTSLAW, in the e-newsletter Special Ed Advocate, focuses on FAPE in the most current issue. Fighting for FAPE at your school? Check it out.

No comments: